Annals of Oncology

introduction:

The European Society for Medical Oncology (ESMO)
Ann Oncol 18: ix1; doi:10.1093/annonc/mdm383
[PDF] [Request Permissions]

European Society for Medical Oncology – Committees
Ann Oncol 18: ix2-ix3; doi:10.1093/annonc/mdm384
[PDF] [Request Permissions]

National representatives
Ann Oncol 18: ix4; doi:10.1093/annonc/mdm385
[PDF] [Request Permissions]

ESMO Educational Structure
Ann Oncol 18: ix5; doi:10.1093/annonc/mdm386
[PDF] [Request Permissions]

ESMO Educational Structure
Ann Oncol 18: ix6-ix8; doi:10.1093/annonc/mdm387
[PDF] [Request Permissions]

ESMO Fellowship Program
Ann Oncol 18: ix9-ix10; doi:10.1093/annonc/mdm388
[PDF] [Request Permissions]

ESMO Young Oncologists
Ann Oncol 18: ix11; doi:10.1093/annonc/mdm389
[PDF] [Request Permissions]

ESMO Membership Services
Ann Oncol 18: ix12; doi:10.1093/annonc/mdm390
[PDF] [Request Permissions]

ESMO Foundation
Ann Oncol 18: ix13; doi:10.1093/annonc/mdm391
[PDF] [Request Permissions]

Acknowledgements
Ann Oncol 18: ix14-ix15; doi:10.1093/annonc/mdm392
[PDF] [Request Permissions]

ESMO Conference Lugano (ECLU) 2007 Officers and Organization
Ann Oncol 18: ix16; doi:10.1093/annonc/mdm393
[PDF] [Request Permissions]

Introduction from Dr. Andrés Cervantes ECLU 2007 Working Group Chair
Ann Oncol 18: ix17; doi:10.1093/annonc/mdm394
[PDF] [Request Permissions]

meet the professor sessions:

S Di Cosimo and J Baselga

Pharmacodynamic endpoints in primary breast cancer
Ann Oncol 18: ix21-ix23; doi:10.1093/annonc/mdm288
[PDF] [Request Permissions]

S Marsh

Pharmacogenomics
Ann Oncol 18: ix24-ix28; doi:10.1093/annonc/mdm289
[PDF] [Request Permissions]

EA Eisenhauer

Response evaluation: beyond RECIST
Ann Oncol 18: ix29-ix32; doi:10.1093/annonc/mdm290
[PDF] [Request Permissions]

F André, J Domont, and S Delaloge

What can breast cancer molecular sub-classification add to conventional diagnostic tools?
Ann Oncol 18: ix33-ix36; doi:10.1093/annonc/mdm291
[PDF] [Request Permissions]

D Schrijvers

Pain control in cancer: recent findings and trends
Ann Oncol 18: ix37-ix42; doi:10.1093/annonc/mdm292
[PDF] [Request Permissions]

F Roila, M Garassino, and S Fatigoni

New anti-emetic treatments
Ann Oncol 18: ix43-ix47; doi:10.1093/annonc/mdm293
[PDF] [Request Permissions]

advances in the treatment of hematological malignancies:

A López-Guillermo and S Mercadal

The clinical use of antibodies in haematological malignancies
Ann Oncol 18: ix51-ix57; doi:10.1093/annonc/mdm294
[PDF] [Request Permissions]

A Hochhaus

Advances in the treatment of haematological malignancies: optimal sequence of CML treatment
Ann Oncol 18: ix58-ix63; doi:10.1093/annonc/mdm295
[PDF] [Request Permissions]

H Ludwig, K Strasser-Weippl, M Schreder, and N Zojer

Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma
Ann Oncol 18: ix64-ix70; doi:10.1093/annonc/mdm296
[PDF] [Request Permissions]

V Diehl and M Fuchs

Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies
Ann Oncol 18: ix71-ix79; doi:10.1093/annonc/mdm297
[PDF] [Request Permissions]

new challenges in kidney cancer therapy:

H Izzedine, B Billemont, F Thibault, and O Rixe

New challenges in kidney cancer therapy: sunitinib
Ann Oncol 18: ix83-ix86; doi:10.1093/annonc/mdm298
[PDF] [Request Permissions]

ME Gore

Temsirolimus in the treatment of advanced renal cell carcinoma
Ann Oncol 18: ix87-ix88; doi:10.1093/annonc/mdm299
[PDF] [Request Permissions]

A Ravaud

New challenges in kidney cancer therapy: bevacizumab
Ann Oncol 18: ix89; doi:10.1093/annonc/mdm300
[PDF] [Request Permissions]

B Escudier

Sorafinib in kidney cancer
Ann Oncol 18: ix90-ix93; doi:10.1093/annonc/mdm301
[PDF] [Request Permissions]

J Wagstaff

Renal cell cancer: is immunotherapy dead?
Ann Oncol 18: ix94-ix97; doi:10.1093/annonc/mdm302
[PDF] [Request Permissions]

PHM De Mulder

Targeted therapy in metastatic renal cell carcinoma
Ann Oncol 18: ix98-ix102; doi:10.1093/annonc/mdm303
[PDF] [Request Permissions]

multidisciplinary treatment of rectal cancer:

E Deutsch, P Ezra, M Mangoni, and M Ducreux

Radiotherapy for localized rectal cancer
Ann Oncol 18: ix105-ix113; doi:10.1093/annonc/mdm304
[PDF] [Request Permissions]

C Aschele and S Lonardi

Multidisciplinary treatment of rectal cancer: medical oncology
Ann Oncol 18: ix114-ix121; doi:10.1093/annonc/mdm305
[PDF] [Request Permissions]

ID Nagtegaal and JHJM van Krieken

The multidisciplinary treatment of rectal cancer: pathology
Ann Oncol 18: ix122-ix126; doi:10.1093/annonc/mdm306
[PDF] [Request Permissions]

A Cervantes, E Rodríguez-Braun, S Navarro, A Hernández, S Campos, and E García-Granero

Integrative decisions in rectal cancer
Ann Oncol 18: ix127-ix131; doi:10.1093/annonc/mdm307
[PDF] [Request Permissions]

hot topics in lung cancer:

B Besse, S Ropert, and JC Soria

Targeted therapies in lung cancer
Ann Oncol 18: ix135-ix142; doi:10.1093/annonc/mdm308
[PDF] [Request Permissions]

E Felip, S Cedrés, S Peralta, and A Prat

Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
Ann Oncol 18: ix143-ix146; doi:10.1093/annonc/mdm309
[PDF] [Request Permissions]

RA Stahel

Adenocarcinoma, a molecular perspective
Ann Oncol 18: ix147-ix149; doi:10.1093/annonc/mdm310
[PDF] [Request Permissions]

L Toschi, F Cappuzzo, and PA Jänne

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer
Ann Oncol 18: ix150-ix155; doi:10.1093/annonc/mdm311
[PDF] [Request Permissions]

abstracts section:

european school of oncology symposium: new drug development
Ann Oncol 18: ix157-ix158; doi:10.1093/annonc/mdm312
[PDF] [Request Permissions]

basic science and bench to bedside (lab)
Ann Oncol 18: ix159-ix160; doi:10.1093/annonc/mdm313
[PDF] [Request Permissions]

breast cancer
Ann Oncol 18: ix161-ix162; doi:10.1093/annonc/mdm314
[PDF] [Request Permissions]

breast cancer, advanced
Ann Oncol 18: ix163-ix164; doi:10.1093/annonc/mdm315
[PDF] [Request Permissions]

breast cancer, early
Ann Oncol 18: ix165-ix167; doi:10.1093/annonc/mdm316
[PDF] [Request Permissions]

colorectal cancer
Ann Oncol 18: ix168-ix172; doi:10.1093/annonc/mdm317
[PDF] [Request Permissions]

genitourinary tumors
Ann Oncol 18: ix173-ix174; doi:10.1093/annonc/mdm318
[PDF] [Request Permissions]

gynecological cancer
Ann Oncol 18: ix175; doi:10.1093/annonc/mdm319
[PDF] [Request Permissions]

head and neck cancer
Ann Oncol 18: ix176-ix177; doi:10.1093/annonc/mdm320
[PDF] [Request Permissions]

hematological malignancies
Ann Oncol 18: ix178-ix182; doi:10.1093/annonc/mdm321
[PDF] [Request Permissions]

lung cancer
Ann Oncol 18: ix183-ix185; doi:10.1093/annonc/mdm322
[PDF] [Request Permissions]

melanoma and sarcoma
Ann Oncol 18: ix186; doi:10.1093/annonc/mdm323
[PDF] [Request Permissions]

molecular mechanism implemented in clinical practice
Ann Oncol 18: ix187; doi:10.1093/annonc/mdm324
[PDF] [Request Permissions]

neuroendocrine tumors and cup
Ann Oncol 18: ix188-ix189; doi:10.1093/annonc/mdm325
[PDF] [Request Permissions]

neuro-oncology
Ann Oncol 18: ix190; doi:10.1093/annonc/mdm326
[PDF] [Request Permissions]

prevention and screening
Ann Oncol 18: ix191-ix192; doi:10.1093/annonc/mdm327
[PDF] [Request Permissions]

psycho-oncology
Ann Oncol 18: ix193; doi:10.1093/annonc/mdm328
[PDF] [Request Permissions]

supportive care
Ann Oncol 18: ix194; doi:10.1093/annonc/mdm329
[PDF] [Request Permissions]

supportive and palliative care
Ann Oncol 18: ix195-ix197; doi:10.1093/annonc/mdm330
[PDF] [Request Permissions]

upper gastrointestinal tumors
Ann Oncol 18: ix198-ix199; doi:10.1093/annonc/mdm333
[PDF] [Request Permissions]

Indexes:

subject index
Ann Oncol 18: ix201-ix202; doi:10.1093/annonc/mdm368
[PDF] [Request Permissions]

author index
Ann Oncol 18: ix203-ix206; doi:10.1093/annonc/mdm369
[PDF] [Request Permissions]

ECLU 2007 Disclosures
Ann Oncol 18: ix207; doi:10.1093/annonc/mdm401
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.